A serotype VIII strain among colonizing group B streptococcal isolates in Boston, Massachusetts

Journal of Clinical Microbiology

Volumn 37, Issue 11, 1999, Pages 3759-3760

  Paoletti, Leanne J ^a   Bradford, Jessica ^b   Paoletti, Lawrence C ^b,c  

^a Clinical Microbiology Department   (Canada)

^b CHANNING LABORATORY   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BACTERIAL COLONIZATION; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; GEOGRAPHIC DISTRIBUTION; NEWBORN DISEASE; NONHUMAN; PRIORITY JOURNAL; RISK FACTOR; SEROPREVALENCE; SEROTYPE; STREPTOCOCCUS AGALACTIAE; UNITED STATES; VACCINATION;

EID: 0032861581     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.37.11.3759-3760.1999     Document Type: Article

References (14)

1. Eickhoff, T. C., J. O. Klein, A. K. Daly, D. Ingall, and M. Finland. 1964. Neonatal sepsis and other infections due to group B beta-hemolytic streptococci. N. Engl. J. Med. 271:1221-1228.
2. Harrison, L. H., J. A. Elliott, D. M. Dwyer, J. P. Libonati, P. Fernen, L. Billmann, and A. Schuchat. 1998. Serotype distribution of invasive group B streptococcal isolates in Maryland: implications for vaccine formulation. J. Infect. Dis. 177:998-1002.
3. Kvam, A. I., A. Efstratiou, L. Bevanger, B. D. Cookson, I. F. Marticorena, R. C. George, and J. A. Maeland. 1995. Distribution of serovariants of group B streptococci in isolates from England and Norway. J. Med. Microbiol. 42:246-250.
4. Lachenauer, C. S., D. L. Kasper, J. Shimada, Y. Ichiman, H. Ohtsuka, M. Kaku, L. C. Paoletti, P. Ferrieri, and L. C. Madoff. 1999. Serotypes VI and VIII predominate among group B streptococci isolated from pregnant Japanese women. J. Infect. Dis. 179:1030-1033.
5. Lancefield, R. C. 1934. A serological differentiation of specific types of bovine hemolytic streptococci (group B). J. Exp. Med. 59:441-458.
6. Lin, F. Y., J. D. Clemens, P. H. Azimi, J. A. Regan, L. E. Weisman, J. B. Philips 3rd, G. G. Rhoads, P. Clark, R. A. Brenner, and P. Ferrieri. 1998. Capsular polysaccharide types of group B streptococcal isolates from neonates with early-onset systemic infection. J. Infect. Dis. 177:790-792.
7. Paoletti, L. C., C. J. Baker, and D. L. Kasper. 1998. Neonatal group B streptococcal disease: progress towards a multivalent maternal vaccine, abstr. P16, p. 43. In The First Annual Conference on Vaccine Research, Washington, D.C.
8. Paoletti, L. C., J. Pinel, K. D. Johnson, B. Reinap, R. A. Ross, and D. L. Kasper. 1999. Synthesis and preclinical evaluation of glycoconjugate vaccines against group B Streptococcus types VI and VIII. J. Infect. Dis. 180:892-895.
9. Paoletti, L. C., M. R. Wessels, F. Michon, J. DiFabio, H. J. Jennings, and D. L. Kasper. 1992. Group B Streptococcus type II polysaccharide-tetanus toxoid conjugate vaccine. Infect. Immun. 60:4009-4014.
10. Paoletti, L. C., M. R. Wessels, A. K. Rodewald, A. A. Shroff, H. J. Jennings, and D. L. Kasper. 1994. Neonatal mouse protection against infection with multiple group B streptococcal (GBS) serotypes by maternal immunization with a tetravalent GBS polysaccharide-tetanus toxoid conjugate vaccine. Infect. Immun. 62:3236-3243.
11. Rench, M. A., and C. J. Baker. 1993. Neonatal sepsis caused by a new group B streptococcal serotype. J. Pediatr. 122:638-640.
12. Schuchat, A. 1998. Epidemiology of group B streptococcal disease in the United States: shifting paradigms. Clin. Microbiol. Rev. 11:497-513.
13. Wessels, M. R., L. C. Paoletti, D. L. Kasper, J. L. DiFabio, F. Michon, K. Holme, and H. J. Jennings. 1990. Immunogenicity in animals of a polysaccharide-protein conjugate vaccine against type III group B Streptococcus. J. Clin. Investig. 86:1428-1433.
14. Wessels, M. R., L. C. Paoletti, A. K. Rodewald, F. Michon, J. DiFabio, H. J. Jennings, and D. L. Kasper. 1993. Stimulation of protective antibodies against type Ia and Ib group B streptococci by a type Ia polysaccharidetetanus toxoid conjugate vaccine. Infect. Immun. 61:4760-4766.